COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

  Director's Message:

Soumita Das Head Shot"Each time a drug program that was successful in pre-clinical animals' models fails to reproduce efficacy in Phase III clinical trials on real-world patients, the society bears a tab of ~$ 2.4B as patients continue to suffer. HUMANOID's stem cell-based multi-dimensional disease models, reverse-engineered using co-cultures of 'all-human' patient-derived organoids, primary cells and even microbes and vetted by omics approaches for accurately recapitulating the human condition is expected to introduce an additional step in drug discovery, i.e., Phase '0' trials, which allows the testing of efficacy and toxicity of drugs so that ineffective candidates can be rejected early."  Soumita Das, Ph.D., Chief Scientific Officer and Founding Co-Director, HUMANOID CoRE

Click here to know more about the Das Lab